Virtual mini-symposium featuring the work of NIH's newest members of the National Academy of Sciences (NAS), Drs. John Schiller (NCI-CCR) and Robert Tycko (NIDDK).
Schiller is a NIH Distinguished Investigator and section chief in the NCI Laboratory of Cellular Oncology. In his 35 years at the NIH, Schiller has studied various aspects of papillomavirus molecular biology, immunology and epidemiology. Together with Doug Lowy, M.D., now NIH Principal Deputy Director, Schiller led in the discovery, characterization, and clinical testing of virus-like particle vaccines to prevent the HPV infections that cause cervical and other cancers. The achievement earned both Schiller and Lowy the 2017 Lasker~DeBakey Clinical Medical Research Award, among other accolades.
Tycko is a Senior Investigator and Chief of the Solid State NMR and Biomolecular Physics Section in the NIDDK Laboratory of Chemical Physics. A physical chemist by training, Tycko's work includes contributions to magnetic resonance methodology, condensed matter physics, biophysics, and structural biology. He is best known recently for applications of solid state nuclear magnetic resonance in structural studies of amyloid fibrils that are associated with neurodegenerative diseases. His previous recognitions include the prestigious Christian B. Anfinsen Award from The Protein Society in 2014.
Schiller and Tycko were elected to the NAS in April 2020. They join a remarkable group of nearly 50 other active NIH principal investigators elected in past years. You can see the full list of NIH NAS members at https://irp.nih.gov/about-us/honors/the-national-academy-of-sciences.
John Schiller, Ph.D., NCI, NIH and Robert Tycko, Ph.D., NIDDK, NIH